SEARCH

SEARCH BY CITATION

References

  • Van Aarle P. G. M., De Barse M. M. J., Veldink G. A. and Vliegenthart J. F. G. (1991) Purification of a lipoxygenase from ungerminated barley. FEBS Lett. 280, 159162.
  • Bari M., Battista N., Fezza F., Gasperi V. and Maccarrone M. (2006) New insights into endocannabinoid degradation and its therapeutic potential. Mini-Rev. Med. Chem. 6, 109120.
  • Bifulco M., Laezza C., Valenti M., Ligresti A., Portella G. and Di Marzo V. (2004) A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J. 18, 16061608.
  • Bifulco M., Laezza C., Pisanti S. and Gazzero P. (2006) Cannabinoids and cancer; pros and cons of an antitumor strategy. Br. J. Pharmacol. 148, 123135.
  • Bisogno T., Howell F., Williams G. et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463468.
  • Blazquez C., Casanova M. L., Planas A., Del Pulgar T. G., Villanueva C., Fernandez-Acenero M. J., Aragones J., Huffman J. W., Jorcano J. L. and Guzman M. (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529531.
  • Brash A. R. (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 2367923682.
  • De Petrocellis L. and Di Marzo V. (2005) Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci. 77, 16511666.
  • Derkinderen P., Valjent E., Toutant M., Corvol J. C., Enslen H., Ledent C., Trzaskos J., Caboche J. and Girault J. A. (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 23712382.
  • Derocq J. M., Bouaboula M., Marchand J., Rinaldi-Carmona M., Segui M. and Casellas P. (1998) The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett. 425, 419425.
  • Dinh T. P., Carpenter D., Leslie F. M., Freund T. F., Katona I., Sensi S. L., Kathuria S. and Piomelli D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. USA 99, 1081910824.
  • Drysdale A. J., Ryan D., Pertwee R. G. and Platt B. (2006) Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. Neuropharmacology 50, 621631.
  • Eichele K., Weinzierl U., Ramer R., Brune K. and Hinz B. (2006) R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells. Pharm. Res. 23, 9094.
  • Fernandez-Ruiz J., Romero J., Velasco G., Tolon R. M., Ramos J. A. and Guzman M. (2006) Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol. Sci. 28, 3945.
  • Fezza F., Gasperi V., Mazzei C. and Maccarrone M. (2005) Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. Anal. Biochem. 339, 113120.
  • Finazzi-Agrò A., Avigliano L., Veldink G. A., Vliegenthart J. F. G. and Boldingh J. (1973) The influence of oxygen on the fluorescence of lipoxygenase. Biochim. Biophys. Acta 326, 462470.
  • Fride E., Barg J., Levy R., Saya D., Heldman E., Mechoulam R. and Vogel Z. (1995) Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 272, 699707.
  • Funk C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 18711875.
  • Furstenberger G., Krieg P., Muller-Decker K. and Habenicht A. J. (2006) What are cyclooxygenases and lipoxygenases doing in the driver’s seat of carcinogenesis? Int. J. Cancer 119, 22472254.
  • Gardner B., Zhu L. X., Sharma S., Tashkin D. P. and Dubinett S. M. (2003) Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. FASEB J. 17, 21572159.
  • Guzman M. (2003) Cannabinoids: potential anticancer agents. Nat. Rev. Cancer 3, 745755.
  • Hart S., Fischer O. M. and Ullrich A. (2004) Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64, 19431950.
  • Jacobsson S. O., Wallin T. and Fowler C. J. (2001) Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299, 951959.
  • Jakobsson P. J., Steinhilber D., Odlander B., Radmark O., Claesson H. E. and Samuelsson B. (1992) On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc. Natl Acad. Sci. USA 89, 35213525.
  • Jonsson K. O., Andersson A., Jacobsson S. O., Vandevoorde S., Lambert D. M. and Fowler C. J. (2003) AM404 and VDM11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide. Arch. Toxicol. 77, 201207.
  • Jonsson K. O., Holt S. and Fowler C. J. (2006) The endocannabinoid system: current pharmacological research and therapeutic possibilities. Basic Clin. Pharmacol. Toxicol. 98, 124134.
  • Kim J. A., Chung Y. J. and Lee Y. S. (1998) Intracellular Ca2+ mediates lipoxygenase-induced proliferation of U-373 MG human astrocytoma cells. Arch. Pharm. Res. 21, 664670.
  • Klegeris A., Bissonnette C. J. and McGeer P. L. (2003) Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br. J. Pharmacol. 139, 775786.
  • Kogan N. M. (2005) Cannabinoids and cancer. Mini Rev. Med. Chem. 5, 941952.
  • Kozak K. R., Prusakiewicz J. J. and Marnett L. J. (2004) Oxidative metabolism of endocannabinoids by COX-2. Curr. Pharm. Des. 10, 659667.
  • Kulmacz R. J. and Wang L. H. (1995) Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J. Biol. Chem. 270, 2401924023.
  • Ligresti A., Morello A. S., Starowicz K., Matias I., Pisanti S., De Petrocellis L., Laezza C., Portella G., Bifulco M. and Di Marzo V. (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharmacol. Exp. Ther. 318, 13751387.
  • Maccarrone M. (2006) Involvement of the endocannabinoid system in cancer, in Endocannabinoids: The Brain and Body’s Marijuana and Beyond (OnaiviE. S., SugiuraT. and Di MarzoV., eds), pp. 451466. CRC Press, Boca Raton.
  • Maccarrone M., Van Der Stelt M., Rossi A., Veldink G. A., Vliegenthart J. F. G. and Finazzi Agrò A. (1998) Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem. 273, 3233232339.
  • Maccarrone M., Bari M., Corasaniti M. T., Nisticò R., Bagetta G. and Finazzi Agrò A. (2000a) HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favour of prostanoids. J. Neurochem. 75, 196203.
  • Maccarrone M., Fiorucci L., Erba F., Bari M., Finazzi Agrò A. and Ascoli F. (2000b) Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett. 468, 176180.
  • Maccarrone M., Salucci M. L., Van Zadelhoff G., Malatesta F., Veldink G., Vliegenthart J. F. G. and Finazzi-Agrò A. (2001) Tryptic digestion of soybean lipoxygenase-1 generates a 60 kDa fragment with improved activity and membrane binding ability. Biochemistry 40, 68196827.
  • Maccarrone M., Navarra M., Catani V., Corasaniti M. T., Bagetta G. and Finazzi-Agrò A. (2002) Cholesterol-dependent modulation of the toxicity of HIV-1 coat protein gp120 in human neuroblastoma cells. J. Neurochem. 82, 14441452.
  • Maccarrone M., Barboni B., Paradisi A., Bernabo N., Gasperi V., Pistilli M. G., Fezza F., Lucidi P. and Mattioli M. (2005) Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J. Cell Sci. 118, 43934404.
  • Manev H., Uz T., Sugaya K. and Qu T. (2000) Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 14, 14641469.
  • Massi P., Vaccani A., Ceruti S., Colombo A., Abbracchio M. P. and Parolaro D. (2004) Antitumor effects of cannabidiol, a non psychoactive cannabinoid, on human glioma cell lines. J. Pharmacol. Exp. Ther. 308, 838845.
  • Massi P., Vaccani A., Bianchessi S., Costa B., Macchi P. and Parolaro D. (2006) The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell. Mol. Life Sci. 63, 20572066.
  • McKallip R. J., Jia W., Schlomer J., Warren J. W., Nagarkatti P. S. and Nagarkatti M. (2006) Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol. Pharmacol. 70, 897908.
  • Montine T. J. and Morrow J. D. (2005) Fatty acid oxidation in the pathogenesis of Alzheimer’s disease. Am. J. Pathol. 166, 12831289.
  • Nathoo N., Prayson R. A., Bondar J., Vargo L., Arrigain S., Mascha E. J., Suh J. H., Barnett G. H. and Golubic M. (2006) Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery 58, 347354.
  • Osti D., Marras E., Ceriani I., Grassini G., Rubino T., Viganò D., Parolaro D. and Perletti G. (2006) Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. J. Virol. Methods 136, 93101.
  • Patsos H. A., Hicks D. J., Dobson R. R., Greenhough A., Woodman N., Lane J. D., Williams A. C. and Paraskeva C. (2005) The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 54, 741750.
  • Petersen G., Moesgaard B., Schmid P. C., Schmid H. H., Broholm H., Kosteljanetz M. and Hansen H. (2005) Endocannabinoid metabolism in human glioblastoma and meningiomas compared to human non-tumor brain tissue. J. Neurochem. 93, 299309.
  • Ross R. A., Gibson T. M., Brockie H. C., Leslie M., Pashmi G., Craib S. J., Di Marzo V. and Pertwee R. G. (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 132, 631640.
  • Ruiz L., Miguel A. and Diaz-Laviada I. (1999) Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett. 458, 400404.
  • Van Der Stelt M., Van Kuik J. A., Bari M., Van Zadelhoff G., Leeflang B. R., Veldink G. A., Finazzi- Agrò A., Vliegenthart J. F. G. and Maccarrone M. (2002) Oxygenated metabolites of anandamide and 2-arachidonoyl-glycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter and fatty acid amide hydrolase. J. Med. Chem. 45, 37093720.
  • Sulcova E., Mechoulam R. and Fride E. (1998) Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59, 347352.
  • Vaccani A., Massi P., Colombo A., Rubino T. and Parolaro D. (2005) Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br. J. Pharmacol. 144, 10321036.
  • Werz O. and Steinhilber D. (2006) Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol. Ther. 112, 701718.